Male Pattern Baldness May Indicate An Increased Risk For Prostate Cancer Death

Male Pattern Baldness May Indicate An Increased Risk For Prostate Cancer Death

For years, several studies have repeatedly linked male pattern baldness to an increased risk for prostate cancer. This association makes sense as hormones called androgens play a role in both hair loss and the development of prostate cancer. Additionally both conditions are also recognized as having genetic origins to a certain degree. Despite the association, many health experts still agree that the main risk factors for prostate cancer consist of advanced age, family history, ethnic background and genetic mutations.

According to a recent study conducted by The National Cancer Institute, researchers found that men with any varying degree of male pattern baldness had an increased risk of dying from prostate cancer. Using male pattern baldness as a proxy for long-term androgen exposure, Dr. Cook and his colleagues studied PCa-specific mortality and extent of baldness in 4,316 men aged 25–74 years from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study (1971–1974). Of 3,284 deaths occurring during 21 years of follow-up, 107 were due to PCa, according to results.

Researchers also discovered that men with any form of balding were found to have a 56 percent higher risk of deadly prostate cancer than those with no balding at all. In addition, those who had moderate balding were associated with an even higher risk of 83 percent. Despite the team’s findings lead researcher Dr. Michael Cook felt that baldness was not certain as a risk factor for prostate cancer. Further adding,

In the future, patterns and degree of male baldness may play a small role in estimating risk of prostate cancer and may contribute to patient-doctor discussions about whether to opt for prostate cancer screening.”

Co-author Cindy Zhou also said that it is not yet time to recommend screening tweaks based on their study findings. She adds that they will need more research to replicate the results.Their results however do help to raise an important point that supports the role of biological mechanisms in both balding and prostate cancer. According to Cook and his associates, more research is required in order to identify the relation between prostate cancer and distinct patterns of baldness.

The research team’s findings were published in the American Journal of Epidemiology.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

David Samadi Headshot

Dr. David Samadi M.D.


Dr. David Samadi is a board certified urologic oncologist trained in open and traditional and laparoscopic surgery and is an expert in robotic prostate surgery. He is Chairman of Urology, and Chief of Robotic Surgery at Lenox Hill Hospital.

Dr. David Samadi is also part of the Fox News Medical A Team as a medical correspondent and the Chief Medical Correspondent for am970 in New York City. He has dedicated his distinguished career to the early detection, diagnosis and treatment of prostate cancer and is considered one of the most prominent surgeons in his field.

FoundationLogo

For more comprehensive information about prostate cancer, detecting prostate cancer, how to live with prostate cancer, and how to help support the fight against prostate cancer, please visit:
Samadi Robotics Foundation

ProstateCancer911Logo

For more up to date prostate cancer news, please visit: Prostate Cancer 911

RoboticOncology

To learn more about Dr. David Samadi and his practice, visit: Robotic Oncology

Translate »